Raul Parra Jr. - Nov 7, 2024 Form 4 Insider Report for MERIT MEDICAL SYSTEMS INC (MMSI)

Role
CFO AND TREASURER
Signature
/s/ Brian G. Lloyd, Attorney-in-Fact
Stock symbol
MMSI
Transactions as of
Nov 7, 2024
Transactions value $
-$345,624
Form type
4
Date filed
11/12/2024, 06:00 AM
Previous filing
Nov 7, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MMSI Common Stock, No Par Value Options Exercise $202K +5.36K +32.77% $37.71 21.7K Nov 7, 2024 Direct
transaction MMSI Common Stock, No Par Value Sale -$548K -5.36K -24.68% $102.18 16.4K Nov 7, 2024 Direct F2
holding MMSI Common Stock, No Par Value 2.77K Nov 7, 2024 By 401(k) Plan F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MMSI Non-qualified stock options (right to buy) Options Exercise $0 -5.36K -50% $0.00 5.36K Nov 7, 2024 Common Stock 5.36K $37.71 Direct F3
holding MMSI Non-qualified stock options (right to buy) 9.68K Nov 7, 2024 Common Stock 9.68K $56.25 Direct F4
holding MMSI Non-qualified stock options (right to buy) 14.6K Nov 7, 2024 Common Stock 14.6K $65.03 Direct F5
holding MMSI Non-qualified stock options (right to buy) 13.6K Nov 7, 2024 Common Stock 13.6K $70.58 Direct F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents plan holdings as of 11/07/2024.
F2 The price reported in Column 4 of Table 1 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $102.17 to $102.25, inclusive. The Reporting Person undertakes to provide to Merit Medical Systems, Inc., any security holder of Merit Medical Systems, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
F3 Becomes exercisable in equal annual installments of 25% commencing 02/26/2021.
F4 Becomes exercisable in equal annual installments of 25% commencing on 03/19/2022.
F5 Becomes exercisable in equal annual installments of 25% commencing on 02/28/2023.
F6 Becomes exercisable in equal annual installments of 25% commencing on 02/28/2024.